Posizioni attive di Alan Sokaler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Direttore/Membro del Consiglio | - | - |
| Comptroller/Controller/Auditor | 02/03/2023 | - |
Storia della carriera di Alan Sokaler
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
Posizioni
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Alan Sokaler
- Esperienza
